{"id":"https://openalex.org/W2168973449","doi":"https://doi.org/10.1111/fcp.12014","title":"Drug interactions between antihypertensive drugs and non\u2010steroidal anti\u2010inflammatory agents: a descriptive study using the French Pharmacovigilance database","display_name":"Drug interactions between antihypertensive drugs and non\u2010steroidal anti\u2010inflammatory agents: a descriptive study using the French Pharmacovigilance database","publication_year":2012,"publication_date":"2012-11-02","ids":{"openalex":"https://openalex.org/W2168973449","doi":"https://doi.org/10.1111/fcp.12014","mag":"2168973449","pmid":"https://pubmed.ncbi.nlm.nih.gov/23190210"},"language":"en","primary_location":{"id":"doi:10.1111/fcp.12014","doi":"https://doi.org/10.1111/fcp.12014","is_oa":false,"landing_page_url":"https://doi.org/10.1111/fcp.12014","pdf_url":null,"source":{"id":"https://openalex.org/S35226884","display_name":"Fundamental and Clinical Pharmacology","issn_l":"0767-3981","issn":["0767-3981","1472-8206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental &amp; Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061736192","display_name":"Jean\u2010Pascal Fournier","orcid":"https://orcid.org/0000-0002-9971-0672","observed_orcids":["https://orcid.org/0000-0002-9971-0672"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Jean\u2010Pascal Fournier","raw_affiliation_strings":["D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","UMR 1027 Inserm Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555"]},{"raw_affiliation_string":"Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"raw_affiliation_string":"UMR 1027 Inserm Toulouse France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069068175","display_name":"Agn\u00e8s Sommet","orcid":"https://orcid.org/0000-0001-7980-5650","observed_orcids":["https://orcid.org/0000-0001-7980-5650"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Agn\u00e8s Sommet","raw_affiliation_strings":["Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","Service de Pharmacologie Clinique Centre Midi\u2010Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament, Centre Hospitalier Universitaire de Toulouse France","UMR 1027 Inserm Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"raw_affiliation_string":"Service de Pharmacologie Clinique Centre Midi\u2010Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament, Centre Hospitalier Universitaire de Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"UMR 1027 Inserm Toulouse France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036143753","display_name":"Genevi\u00e8ve Durrieu","orcid":"https://orcid.org/0000-0002-3717-2784","observed_orcids":["https://orcid.org/0000-0002-3717-2784"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Genevi\u00e8ve Durrieu","raw_affiliation_strings":["Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","Service de Pharmacologie Clinique Centre Midi\u2010Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament, Centre Hospitalier Universitaire de Toulouse France","UMR 1027 Inserm Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"raw_affiliation_string":"Service de Pharmacologie Clinique Centre Midi\u2010Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament, Centre Hospitalier Universitaire de Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"UMR 1027 Inserm Toulouse France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105356758","display_name":"Jean-Christophe Poutrain","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean\u2010Christophe Poutrain","raw_affiliation_strings":["D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"D\u00e9partement Universitaire de M\u00e9decine G\u00e9n\u00e9rale, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050870063","display_name":"Maryse Lapeyre\u2010Mestre","orcid":"https://orcid.org/0000-0002-5494-5873","observed_orcids":["https://orcid.org/0000-0002-5494-5873"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Maryse Lapeyre\u2010Mestre","raw_affiliation_strings":["Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","Service de Pharmacologie Clinique Centre Midi\u2010Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament, Centre Hospitalier Universitaire de Toulouse France","UMR 1027 Inserm Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"raw_affiliation_string":"Service de Pharmacologie Clinique Centre Midi\u2010Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament, Centre Hospitalier Universitaire de Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"UMR 1027 Inserm Toulouse France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091020739","display_name":"Jean\u2010Louis Montastruc","orcid":"https://orcid.org/0000-0001-6341-6001","observed_orcids":["https://orcid.org/0000-0001-6341-6001"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]},{"id":"https://openalex.org/I4405258862","display_name":"Universit\u00e9 de Toulouse","ror":"https://ror.org/01ahyrz84","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean\u2010Louis Montastruc","raw_affiliation_strings":["Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","Service de Pharmacologie Clinique Centre Midi\u2010Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament, Centre Hospitalier Universitaire de Toulouse France","UMR 1027 Inserm Toulouse France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacologie M\u00e9dicale et Clinique, Facult\u00e9 de M\u00e9decine Universit\u00e9 Paul Sabatier Toulouse France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"raw_affiliation_string":"Service de Pharmacologie Clinique Centre Midi\u2010Pyr\u00e9n\u00e9es de Pharmacovigilance, de Pharmaco\u00e9pid\u00e9miologie et d'Information sur le M\u00e9dicament, Centre Hospitalier Universitaire de Toulouse France","institution_ids":["https://openalex.org/I3019448017"]},{"raw_affiliation_string":"UMR 1027 Inserm Toulouse France","institution_ids":["https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5061736192"],"corresponding_institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488","https://openalex.org/I4405258862"],"apc_list":{"value":3300,"currency":"USD","value_usd":3300},"apc_paid":null,"fwci":5.3288,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.94907326,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"28","issue":"2","first_page":"230","last_page":"235"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8500999808311462,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.8500999808311462,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.12049999833106995,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9879999756813049},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.9779999852180481},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9850000143051147},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.984000027179718},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.9750000238418579},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9369999766349792},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":1.0},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.9869999885559082},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8519999980926514},{"id":"https://openalex.org/keywords/guideline-implementation","display_name":"guideline implementation","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.862354576587677},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5545140504837036},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5514876246452332},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45919597148895264},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.4302443861961365},{"id":"https://openalex.org/C39896193","wikidata":"https://www.wikidata.org/wiki/Q380344","display_name":"Descriptive statistics","level":2,"score":0.4105806350708008},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.14861643314361572},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060735","descriptor_name":"Pharmacovigilance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D062313","descriptor_name":"Databases, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/fcp.12014","doi":"https://doi.org/10.1111/fcp.12014","is_oa":false,"landing_page_url":"https://doi.org/10.1111/fcp.12014","pdf_url":null,"source":{"id":"https://openalex.org/S35226884","display_name":"Fundamental and Clinical Pharmacology","issn_l":"0767-3981","issn":["0767-3981","1472-8206"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental &amp; Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:23190210","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23190210","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Fundamental & clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-03538375v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-03538375","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Fundamental & Clinical Pharmacology, 2014, 28 (2), pp.230-235. &#x27E8;10.1111/fcp.12014&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W150702799","https://openalex.org/W1893687614","https://openalex.org/W1981710340","https://openalex.org/W1989245429","https://openalex.org/W1990949624","https://openalex.org/W1995194227","https://openalex.org/W1996247594","https://openalex.org/W1998379142","https://openalex.org/W2010783249","https://openalex.org/W2014055299","https://openalex.org/W2038876111","https://openalex.org/W2057262891","https://openalex.org/W2079467429","https://openalex.org/W2085752173","https://openalex.org/W2098058211","https://openalex.org/W2111346661","https://openalex.org/W2146988769","https://openalex.org/W2153972688","https://openalex.org/W2294307268","https://openalex.org/W2417092477","https://openalex.org/W3119182771"],"related_works":["https://openalex.org/W2056533196","https://openalex.org/W1992888592","https://openalex.org/W1830658607","https://openalex.org/W1989438928","https://openalex.org/W2808845167","https://openalex.org/W621814393","https://openalex.org/W7030600374","https://openalex.org/W7029424440","https://openalex.org/W7160965576","https://openalex.org/W2060514620"],"abstract_inverted_index":{"Drug-drug":[0],"interactions":[1],"(DDIs)":[2],"between":[3,67,90,134,153],"antihypertensive":[4,53,68,88,137,185],"drugs":[5,9,69,89,113,138,186],"and":[6,60,70,92,96,116,119,136,155],"non-steroidal":[7],"anti-inflammatory":[8],"(NSAIDs)":[10],"can":[11],"lead":[12],"to":[13,21,42,65,103],"adverse":[14],"drug":[15,27],"reactions":[16],"(ADRs).":[17],"Guidelines":[18],"are":[19,187],"available":[20],"help":[22],"prescribers":[23],"deal":[24],"with":[25,52,86,123,189],"these":[26],"associations,":[28],"but":[29],"their":[30],"implementation":[31],"is":[32,202],"not":[33,203],"well":[34],"evaluated.":[35],"The":[36],"aims":[37],"of":[38,46,77,128,143,181],"this":[39,81,199],"study":[40],"were":[41,107,117],"assess":[43],"the":[44,56,62,73,141,144,167,175],"prevalence":[45],"NSAIDs":[47,135,154,183],"exposure":[48,102],"in":[49,80,83,114,174],"patients":[50,84],"treated":[51,85,122],"drugs,":[54],"using":[55],"French":[57,176],"Pharmacovigilance":[58,177],"database,":[59,178],"explore":[61],"ADRs":[63,78],"related":[64],"DDIs":[66,152],"NSAIDs.":[71,104],"Over":[72],"11,":[74],"442":[75],"notifications":[76],"recorded":[79],"database":[82],"oral":[87],"2008":[91],"2010,":[93],"517":[94],"(4.5":[95],"95%":[97],"CI:":[98],"4.1-4.9)":[99],"also":[100],"included":[101],"These":[105],"subjects":[106],"more":[108,112],"frequently":[109,121,169],"women,":[110],"took":[111],"general,":[115],"younger":[118],"less":[120],"antiplatelet":[124],"drugs.":[125],"In":[126],"24.2%":[127],"them":[129],"(125":[130],"patients),":[131],"a":[132,190],"DDI":[133,201],"was":[139,166],"potentially":[140],"cause":[142],"reported":[145,170],"ADR.":[146],"Acute":[147],"renal":[148,195],"failure":[149],"caused":[150],"by":[151,208],"angiotensin-converting":[156],"enzyme":[157],"inhibitors":[158],"(ACEIs),":[159],"angiotensin":[160],"receptor":[161],"blockers":[162],"(ARBs),":[163],"or":[164],"diuretics":[165],"most":[168],"ADR":[171,192],"(20.7%).":[172],"Finally,":[173],"around":[179],"one-fourth":[180],"associations":[182],"+":[184],"associated":[188],"'serious'":[191],"(mainly":[193],"acute":[194],"failure),":[196],"suggesting":[197],"that":[198],"well-known":[200],"enough":[204],"taken":[205],"into":[206],"account":[207],"prescribers.":[209]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}
